A new oral hypoglycemia agent: 1-methyl-4-(3-methyl-5-isoxazolyl)pyridinium chloride.
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002645:Chickens; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D006168:Guinea Pigs; D006943:Hyperglycemia / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D011726:Pyridinium Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D013045:Species Specificity
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D011726:Pyridinium Compounds